(R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE
Synonym(s):(R)-Etiracetam;(2R)-2-(2-Oxopyrrolidin-1-yl)butanamide
- CAS NO.:103765-01-1
- Empirical Formula: C8H14N2O2
- Molecular Weight: 170.21
- MDL number: MFCD00867782
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-04-23 13:52:06
What is (R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE?
The Uses of (R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE
(R)-Levetiracetam [REV] (Levetiracetam EP Impurity D), is the enantiomer to Levetiracetam [LEV] (L331500), the antiepileptic drug that is highly enantioselective. It is apparent that [LEV] is more potent than [REV] in terms of antiepileptic potency.
Properties of (R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE
Melting point: | 114-116 °C(Solv: acetone (67-64-1)) |
Boiling point: | 395.9±25.0 °C(Predicted) |
Density | 1.168±0.06 g/cm3(Predicted) |
storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere |
solubility | Acetone (Sparingly, Sonicated), Chloroform (Slightly), Methanol (Slightly) |
form | neat |
pka | 15.74±0.50(Predicted) |
color | White to Off-White |
Safety information for (R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 Environment GHS09 |
GHS Hazard Statements |
H302:Acute toxicity,oral H319:Serious eye damage/eye irritation H411:Hazardous to the aquatic environment, long-term hazard |
Precautionary Statement Codes |
P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P270:Do not eat, drink or smoke when using this product. P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P301+P312:IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for (R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE
Abamectin manufacturer
Clickchem Research LLP
1Y
Phone:+91-8140031133
Whatsapp: +91- 8140031133
product: LEVETIRACETAM EP IMP D 103765-01-1 90 % Above
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
Etiracetam
Levetiracetam
Levetiracetam impurity 8
Levetiracetam acid
LevetiracetaM IMpurity B
(S)-N-(1-aMino-1-oxobutan-2-yl)-4-chlorobutanaMide
alpha-Ethyl-2-oxo-1-pyrrolidineacetic acid
Levetiracetam impurity 6
You may like
-
LEVETIRACETAM EP IMP D 103765-01-1 90 % AboveView Details
103765-01-1 -
Levetiracetam impurity D CAS 103765-01-1View Details
103765-01-1 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
1784294-80-9 98%View Details
1784294-80-9 -
Lithium ClavulanateView Details
61177-44-4
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.